Publication: Dietary Marine ω-3 Fatty Acids and Incident Sight-Threatening Retinopathy in Middle-Aged and Older Individuals With Type 2 Diabetes: Prospective Investigation From the PREDIMED Trial.
dc.contributor.author | Sala-Vila, Aleix | |
dc.contributor.author | Díaz-López, Andrés | |
dc.contributor.author | Valls-Pedret, Cinta | |
dc.contributor.author | Cofán, Montserrat | |
dc.contributor.author | García-Layana, Alfredo | |
dc.contributor.author | Lamuela-Raventós, Rosa-María | |
dc.contributor.author | Castañer, Olga | |
dc.contributor.author | Zanon-Moreno, Vicente | |
dc.contributor.author | Martinez-Gonzalez, Miguel A | |
dc.contributor.author | Toledo, Estefanía | |
dc.contributor.author | Basora, Josep | |
dc.contributor.author | Salas-Salvadó, Jordi | |
dc.contributor.author | Corella, Dolores | |
dc.contributor.author | Gómez-Gracia, Enrique | |
dc.contributor.author | Fiol, Miquel | |
dc.contributor.author | Estruch, Ramón | |
dc.contributor.author | Lapetra, José | |
dc.contributor.author | Fitó, Montserrat | |
dc.contributor.author | Arós, Fernando | |
dc.contributor.author | Serra-Majem, Luis | |
dc.contributor.author | Pintó, Xavier | |
dc.contributor.author | Ros, Emilio | |
dc.contributor.author | Prevención con Dieta Mediterránea (PREDIMED) Investigators | |
dc.date.accessioned | 2023-01-25T08:35:37Z | |
dc.date.available | 2023-01-25T08:35:37Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Diabetic retinopathy (DR) is a devastating complication of individuals with type 2 diabetes mellitus. The retina is rich in long-chain ω-3 polyunsaturated fatty acids (LCω3PUFAs), which are substrate for oxylipins with anti-inflammatory and antiangiogenic properties. Experimental models support dietary LCω3PUFA protection against DR, but clinical data are lacking. To determine whether LCω3PUFA intake relates to a decreased incidence of sight-threatening DR in individuals with type 2 diabetes older than 55 years. In late 2015, we conceived a prospective study within the randomized clinical trial Prevención con Dieta Mediterránea (PREDIMED), testing Mediterranean diets supplemented with extra virgin olive oil or nuts vs a control diet for primary cardiovascular prevention. The trial was conducted in primary health care centers in Spain. From 2003 to 2009, 3614 individuals aged 55 to 80 years with a previous diagnosis of type 2 diabetes were recruited. Full data were available for 3482 participants (48% men; mean age 67 years). Meeting the dietary LCω3PUFA recommendation of at least 500 mg/d for primary cardiovascular prevention, as assessed by a validated food-frequency questionnaire. The main outcome was incident DR requiring laser photocoagulation, vitrectomy, and/or antiangiogenic therapy confirmed by an external adjudication committee. Of the 3482 participants, 48% were men and the mean age was 67 years. A total of 2611 participants (75%) met target LCω3PUFA recommendation. During a median follow-up of 6 years, we documented 69 new events. After adjusting for age, sex, intervention group, and lifestyle and clinical variables, participants meeting the LCω3PUFA recommendation at baseline (≥500 mg/d) compared with those not fulfilling this recommendation ( In middle-aged and older individuals with type 2 diabetes, intake of at least 500 mg/d of dietary LCω3PUFA, easily achievable with 2 weekly servings of oily fish, is associated with a decreased risk of sight-threatening DR. Our results concur with findings from experimental models and the current model of DR pathogenesis. clinicaltrials.gov Identifier: http://www.controlled-trials.com/ISRCTN35739639. | |
dc.identifier.doi | 10.1001/jamaophthalmol.2016.2906 | |
dc.identifier.essn | 2168-6173 | |
dc.identifier.pmid | 27541690 | |
dc.identifier.unpaywallURL | https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2543478/eoi160065.pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/10370 | |
dc.issue.number | 10 | |
dc.journal.title | JAMA ophthalmology | |
dc.journal.titleabbreviation | JAMA Ophthalmol | |
dc.language.iso | en | |
dc.organization | Sevilla | |
dc.page.number | 1142-1149 | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Multicenter Study | |
dc.pubmedtype | Randomized Controlled Trial | |
dc.rights.accessRights | open access | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Aged, 80 and over | |
dc.subject.mesh | Diabetes Mellitus, Type 2 | |
dc.subject.mesh | Diabetic Retinopathy | |
dc.subject.mesh | Dietary Supplements | |
dc.subject.mesh | Fatty Acids, Omega-3 | |
dc.subject.mesh | Female | |
dc.subject.mesh | Follow-Up Studies | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Incidence | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Prospective Studies | |
dc.subject.mesh | Risk Assessment | |
dc.subject.mesh | Risk Factors | |
dc.subject.mesh | Seafood | |
dc.subject.mesh | Spain | |
dc.subject.mesh | Time Factors | |
dc.subject.mesh | Treatment Outcome | |
dc.title | Dietary Marine ω-3 Fatty Acids and Incident Sight-Threatening Retinopathy in Middle-Aged and Older Individuals With Type 2 Diabetes: Prospective Investigation From the PREDIMED Trial. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 134 | |
dspace.entity.type | Publication |